As drug developers grapple with partial efficacy and uneven patient response, Tel Aviv-based biotech company Immunai is building an AI-powered immune atlas to explain how therapies work in the body | Read More in ynet – Culture
Iran rejects second round of talks with US – report
Eight children killed in Lousiana mass shooting – NBC
‘Post’ heads to Lebanon: IDF sets position in Ait a Shaab – Reporters Notebook
How Milei brought Judeo-Christian civilization home to Jerusalem – comment
Javier Milei steals spotlight at torch ceremony rehearsal, joins singers in surprise performance
Iran denies Pakistan talks as US pushes ahead; Israel braces for renewed fighting or flawed dealHormuz closure pushed Iran toward negotiationsIran cannot control Strait of Hormuz, retired U.S. Navy admiral saysIran rejects second round of talks with US – reportRemembering Eliot Engel: A life of faithful service – opinionIran cannot control Strait of Hormuz, retired U.S. Navy admiral saysHormuz closure pushed Iran toward negotiations
